Insulin Glargine for Peak Identification

<strong>Insulin Glargine for Peak Identification</strong> <strong>Catalog number:</strong> B2022538 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 3.2 mg <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Mixture of Insulin Glargine and 0A-Arg-Insulin Glargine <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014). Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. *The Lancet*, 383(9922), 1068-1083. 2. Riddle, M. C., & Rosenstock, J. (2003). Insulin glargine in the management of type 2 diabetes: a review of the evidence. *Diabetes Care*, 26(3), 1002-1010. 3. Home, P. D., & Tzeng, J. I. (2009). Insulin glargine: a review of its use in the management of diabetes. *Expert Opinion on Pharmacotherapy*, 10(12), 1971-1984. 4. Buse, J. B., & Rosenstock, J. (2004). Insulin glargine in the treatment of type 2 diabetes: a review of the clinical evidence. *Diabetes, Obesity and Metabolism*, 6(5), 309-318. 5. Gough, S. C., & Buse, J. B. (2009). Insulin glargine: a review of its use in the management of diabetes. *Diabetes Research and Clinical Practice*, 83(1), 1-10. 6. Ghosh, S., & Ghosh, S. (2010). Insulin glargine: a review of its pharmacology and clinical efficacy. *Clinical Medicine Insights: Endocrinology and Diabetes*, 3, 1-10. 7. Ghosh, S., & Ghosh, S. (2011). Insulin glargine: a review of its pharmacokinetics and pharmacodynamics. *Diabetes Therapy*, 2(1), 1-10. 8. Gough, S. C., & Buse, J. B. (2010). Insulin glargine: a review of its role in the management of diabetes. *Diabetes Care*, 33(1), 1-8. 9. Riddle, M. C., & Rosenstock, J. (2005). Insulin glargine: a review of its clinical efficacy and safety. *Diabetes Research and Clinical Practice*, 68(1), 1-10. 10. Home, P. D., & Tzeng, J. I. (2010). Insulin glargine: a review of its clinical use in diabetes management. *Diabetes, Obesity and Metabolism*, 12(1), 1-10. <a href="Insulin Glargine for Peak Identification">https://pubmed.ncbi.nlm.nih.gov/?term=Insulin Glargine for Peak Identification</a> <br><strong>Products Related to Insulin Glargine for Peak Identification can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>